Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    [Renal tumors percutaneous ablation by microwave. Initial experience.]

    Arch Esp Urol 2017 Jun;70(5):525-533
    Residente de Urología. Hospital Universitario Reina Sofía.Córdoba. España.
    Objective: To analyze retrospectively the safety and effectiveness of percutaneous microwave ablation of solid renal tumors, and also review different approach techniques.

    Methods: It is a retrospective study approved by the ethics committee of both hospitals. 14 tumors with a mean size of 37 mm (12-50 mm) were treated in a single session, under general anesthesia and with CT guidance, in 14 patients (9 men) with a mean age of 66 years, using the ablation system AMICA by different approaches (trans pulmonary, trans peritoneal and retroperitoneal). A biopsy was performed with a core needle to 13 of them prior to ablation in the same session. CT abdominal follow-up was performed (with and without i.v. contrast) at 1, 3, 6, 12, 18 and 24 months after ablation. Changes in serum creatinine levels pre- and post-ablation were also analyzed.

    Results: The average follow-up time was 16.5 months (3-28 months) and we obtained complete response in 100% of the treated tumors. Only two minor complications were observed: one self-limited perirenal hemorrhage and one asymptomatic hydronephrosis, in the two patients to whom we did a transpulmonary approach, without pneumothorax in any of them.

    Conclusion: Percutaneous ablation of renal tumors seems to be a safe and effective technique, either via transpulmonary, transperitoneal or retroperitoneal approach, depending on tumor location.

    Key Points: • Microwave ablation produces coagulation necrosis. • The sink effect is smaller in microwave ablation. • Microwave ablation seems to be safe and effective. • The type of approach is not correlated with major complications (Clavien > o =II).

    Similar Publications

    Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
    J Vasc Interv Radiol 2005 May;16(5):679-88
    The Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, 77030-4009, USA.
    Purpose: To report the safety, technical success, and effectiveness of percutaneous radiofrequency (RF) ablation for renal tumors.

    Materials And Methods: The authors retrospectively reviewed the medical records and imaging studies of 29 consecutive patients (18 men, 11 women; mean age, 65 +/- 2.62 years) with 30 renal tumors (mean diameter, 3. Read More
    Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience.
    J Urol 2008 Sep 16;180(3):844-8; discussion 848. Epub 2008 Jul 16.
    Department of Ultrasound, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
    Purpose: We evaluated the feasibility, safety and efficacy of ultrasound guided percutaneous microwave ablation for small renal cell cancers.

    Materials And Methods: A total of 12 patients with a pathologically proven renal cell cancer 1.3 to 3. Read More
    [Radiofrequency ablation of renal tumors: Practical aspects and results].
    Radiologia 2010 May-Jun;52(3):228-33. Epub 2010 Apr 8.
    Servicio de Radiología, Hospital Universitario Reina Sofía, Córdoba, España.
    Objectives: To report our experience in percutaneous radiofrequency ablation of renal tumors, emphasizing technical aspects and indications and analyzing our results.

    Material And Methods: We retrospectively analyzed 20 tumors in 13 patients (10 with a single kidney, 2 who had refused surgical treatment, and 1 with severe comorbidities). All procedures were carried out using the radiofrequency interstitial tumor ablation (RITA) technique under general anesthesia and CT guidance. Read More
    Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
    Acta Radiol 2010 Sep;51(7):808-18
    Department of Urology, Sahlgrenska University Hospital, University of Gothenburg, Sweden.
    Background: Treatment of small renal masses with percutaneous radiofrequency ablation (RFA) is under development. Data are limited regarding the oncologic efficacy and complication rates of ultrasound (US)-guided RFA.

    Purpose: To retrospectively analyze results and factors predictive of incomplete ablation and local recurrence in patients treated for small renal tumors with US-guided percutaneous RFA. Read More